Posted: May 25, 2017

SeQuent Scientific Announces FY17 Financial Results

Q4FY17 marks return to profitability, FY17 Revenues at Rs. 9,151 mn up 47%, EBITDA at Rs. 881mn, up 60%

Mumbai, May 23, 2017 SeQuent Scientific Limited (SeQuent), a leading Integrated Pharmaceutical Company with business across Animal Health (Alivira), Niche Human APIs & Analytical Services today announced its financial results for the fourth quarter (Q4FY17) and full year ended March 31, 2017 (FY17)

Read more
Posted: May 25, 2017

LIVESTOCK & FEED Business

A rebound for Turkey’s broiler fortunes?

Antibiotics used to be administered against the negative effects of NE in poultry. But due to the ban on antibiotics in broilers, there is increasing need for naturally produced alternatives.

Read more
Posted: Aug 3, 2017

SeQuent Scientific Announces Q1 FY18 Financial Results

Strong Revenue Momentum

Q1FY18 Revenues at Rs. 2,605mn up 54%, EBITDA at Rs. 315mn, up 160%

 

Read more
RSS
12